← Literature

Better reporting of harms in randomized trials: an extension of the CONSORT statement.

review • 2004 • ID: 15545678

High Confidence Review

Primary source: [Open]

Linked compounds: semaglutidetirzepatideretatrutide

Outcomes summary

CONSORT extension paper providing guidance on how randomized trials should report harms/adverse events to improve transparency and interpretability.

Limitations

Reporting guideline (not an efficacy study); adherence varies across trials and fields.

Notes

Primary source: PMID 15545678 (see PubMed link on this page).